Success Metrics

Clinical Success Rate
94.9%

Based on 56 completed trials

Completion Rate
95%(56/59)
Active Trials
4(5%)
Results Posted
32%(18 trials)
Terminated
3(4%)

Phase Distribution

Ph phase_4
7
9%
Ph not_applicable
7
9%
Ph phase_2
22
30%
Ph phase_3
33
45%
Ph phase_1
4
5%

Phase Distribution

4

Early Stage

22

Mid Stage

40

Late Stage

Phase Distribution73 total trials
Phase 1Safety & dosage
4(5.5%)
Phase 2Efficacy & side effects
22(30.1%)
Phase 3Large-scale testing
33(45.2%)
Phase 4Post-market surveillance
7(9.6%)
N/ANon-phased studies
7(9.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.8%

56 of 61 finished

Non-Completion Rate

8.2%

5 ended early

Currently Active

4

trials recruiting

Total Trials

74

all time

Status Distribution
Active(4)
Completed(56)
Terminated(5)
Other(9)

Detailed Status

Completed56
unknown9
Active, not recruiting4
Terminated3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
74
Active
4
Success Rate
94.9%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (5.5%)
Phase 222 (30.1%)
Phase 333 (45.2%)
Phase 47 (9.6%)
N/A7 (9.6%)

Trials by Status

completed5676%
terminated34%
unknown912%
withdrawn23%
active_not_recruiting45%

Recent Activity

4 active trials
Showing 5 of 74
active_not_recruitingphase_3

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

NCT02101853
completedphase_3

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

NCT00400946
active_not_recruitingphase_3

Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT01371981
completedphase_2

A Study in Adults With Untreated Acute Lymphoblastic Leukemia

NCT00136435
active_not_recruitingphase_3

Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

NCT02521493
View all 74 trials

Clinical Trials (74)

Showing 20 of 74 trialsScroll for more
NCT02101853Phase 3

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

Active Not Recruiting
NCT00400946Phase 3

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Completed
NCT01371981Phase 3

Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Active Not Recruiting
NCT00136435Phase 2

A Study in Adults With Untreated Acute Lymphoblastic Leukemia

Completed
NCT02521493Phase 3

Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

Active Not Recruiting
NCT03817320Phase 1

PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Active Not Recruiting
NCT00408005Phase 3

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Completed
NCT06676293Not Applicable

Compassionate Use of Asparaginase and Pembrolizumab Combination Theaapy for Nasopharyngeal Carcinoma

Completed
NCT00557193Phase 3

Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Completed
NCT00381680Phase 3

Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

Completed
NCT04187248

The Association Between Asparaginase Enzyme Activity Levels and Toxicities in Childhood Acute Lymphoblastic Leukaemia in NOPHOALL 2008

Completed
NCT00002514Phase 3

Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission

Completed
NCT00198978Phase 4

German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Completed
NCT00199056Phase 4

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)

Completed
NCT00199069Phase 4

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)

Completed
NCT00198991Phase 4

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

Completed
NCT00061945Phase 1

Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

Completed
NCT03668392Phase 2

Asparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL)

Terminated
NCT00369317Phase 3

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes

Completed
NCT01156883Not Applicable

Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia

Completed

Drug Details

Intervention Type
DRUG
Total Trials
74